High-dose preoperative chemoradiotherapy in esophageal cancer patients does not increase postoperative pulmonary complications: Correlation with dose-volume histogram parameters

Radiotherapy and Oncology

Volumn 97, Issue 1, 2010, Pages 60-64

  Hurmuzlu, Meysan ^a,b   Øvrebø, Kjell ^b   Wentzel Larsen, Tore ^c   Muren, Ludvig Paul ^d   Viste, Asgaut ^b   Smaaland, Rune ^e  

^a Section for Rheumatology   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

^e STAVANGER UNIVERSITY HOSPITAL   (Norway)

Author keywords

Dose volume histogram; Esophageal neoplasm; Multimodality therapy; Pulmonary complications; Radiotherapy dosage

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CONTINUOUS INFUSION; CONTROLLED STUDY; DOSE RESPONSE; DRUG MEGADOSE; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HISTOGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PNEUMONIA; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RADIATION DOSE; RESPIRATORY FAILURE; RISK FACTOR; SQUAMOUS CELL CARCINOMA; SURGICAL MORTALITY; TOTAL LUNG CAPACITY;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHI-SQUARE DISTRIBUTION; CISPLATIN; ESOPHAGEAL NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NORWAY; PNEUMONIA; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; RADIOTHERAPY DOSAGE; RESPIRATORY INSUFFICIENCY; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 77957875904     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2010.06.008     Document Type: Article

References (31)

1. S.G. Swisher, L. Deford, and K.W. Merriman Effect of operative volume on morbidity, mortality, and hospital use after esophagectomy for cancer J Thorac Cardiovasc Surg 119 2000 1126 1132
2. B.P. Whooley, S. Law, S.C. Murthy, A. Alexandrou, and J. Wong Analysis of reduced death and complication rates after esophageal resection Ann Surg 233 2001 338 344
3. J.B. Dimick, P.P. Goodney, M.B. Orringer, and J.D. Birkmeyer Specialty training and mortality after esophageal cancer resection Ann Thorac Surg 80 2005 282 286
4. J.B. Hulscher, J.G. Tijssen, H. Obertop, and J.J. Van Lanschot Transthoracic versus transhiatal resection for carcinoma of the esophagus: a meta-analysis Ann Thorac Surg 72 2001 306 313
5. J.M. Omloo, S.Y. Law, and B. Launois Short- and long-term advantages of transhiatal and transthoracic oesophageal cancer resection Eur J Surg Oncol 35 2009 793 797
6. T.N. Walsh, N. Noonan, D. Hollywood, A. Kelly, N. Keeling, and T.P. Hennessy A comparison of multimodal therapy and surgery for esophageal adenocarcinoma N Engl J Med 335 1996 462 467
7. V. Gebski, B. Burmeister, B.M. Smithers, K. Foo, J. Zalcberg, and J. Simes Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis Lancet Oncol 8 2007 226 234
8. M. Rooney, J. Kish, and J. Jacobs Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120-h 5-FU infusion and cisplatin Cancer 55 1985 1123 1128
9. J.L. Bedford, L. Viviers, Z. Guzel, P.J. Childs, S. Webb, and D.M. Tait A quantitative treatment planning study evaluating the potential of dose escalation in conformal radiotherapy of the esophagus Radiother Oncol 57 2000 183 193
10. P.C. Levendag, P.J. Nowak, and M.J. Van der Sangen Local tumor control in radiation therapy of cancers in the head and neck Am J Clin Oncol 19 1996 469 477
11. H.D. Thames Jr., L.J. Peters, W. Spanos Jr., and G.F. Fletcher Dose-response of squamous cell carcinomas of the upper respiratory and digestive tracts Br J Cancer Suppl 4 1980 35 38
12. L.H. Sobin, and C. Wittekind International Union against Cancer: TNM: classification of malignant tumours 6th ed. 2002 Wiley-Liss New York
13. S.L. Wang, Z. Liao, and A.A. Vaporciyan Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery Int J Radiat Oncol Biol Phys 64 2006 692 699 (Pubitemid 43183562)
14. CDC definitions for nosocomial infections, 1988 Am Rev Respir Dis 139 1989 1058 1059
15. Kress John P, Hall Jesse B. Principles of critical care medicine [chapter 261]. In Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, Loscalzo J, editors. Harrison's principles of internal medicine. 17th ed.; 2008. Available from: http://www.accessmedicine.com/content.aspx?aID=2862160.
16. S. Law, K.H. Wong, K.F. Kwok, K.M. Chu, and J. Wong Predictive factors for postoperative pulmonary complications and mortality after esophagectomy for cancer Ann Surg 240 2004 791 800
17. J.R. Doty, J.D. Salazar, A.A. Forastiere, E.I. Heath, L. Kleinberg, and R.F. Heitmiller Postesophagectomy morbidity, mortality, and length of hospital stay after preoperative chemoradiation therapy Ann Thorac Surg 74 2002 227 231 [discussion 231]
18. F.C. Lin, A.E. Durkin, and M.K. Ferguson Induction therapy does not increase surgical morbidity after esophagectomy for cancer Ann Thorac Surg 78 2004 1783 1789
19. S.M. Keller, L.M. Ryan, and L.R. Coia High dose chemoradiotherapy followed by esophagectomy for adenocarcinoma of the esophagus and gastroesophageal junction: results of a phase II study of the Eastern Cooperative Oncology Group Cancer 83 1998 1908 1916
20. J.F. Bosset, M. Gignoux, and J.P. Triboulet Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus N Engl J Med 337 1997 161 167
21. R.M. Abou-Jawde, T. Mekhail, and D.J. Adelstein Impact of induction concurrent chemoradiotherapy on pulmonary function and postoperative acute respiratory complications in esophageal cancer Chest 128 2005 250 255
22. R. Eguchi, H. Ide, and T. Nakamura Analysis of postoperative complications after esophagectomy for esophageal cancer in patients receiving neoadjuvant therapy Jpn J Thorac Cardiovasc Surg 47 1999 552 558
23. B.H. Burmeister, B.M. Smithers, and V. Gebski Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial Lancet Oncol 6 2005 659 668
24. J. Willner, A. Jost, K. Baier, and M. Flentje A little to a lot or a lot to a little? An analysis of pneumonitis risk from dose-volume histogram parameters of the lung in patients with lung cancer treated with 3D conformal radiotherapy Strahlenther Onkol 179 2003 548 556
25. S. Tandon, A. Batchelor, and R. Bullock Peri-operative risk factors for acute lung injury after elective oesophagectomy Br J Anaesth 86 2001 633 638
26. Y. Cui Pulmonary complication after esophagectomy results from multiple factors Ann Thorac Surg 74 2002 1747
27. H.K. Lee, A.A. Vaporciyan, and J.D. Cox Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma: correlation with pulmonary dose-volume histogram parameters Int J Radiat Oncol Biol Phys 57 2003 1317 1322
28. D. Dahn, J. Martell, and H. Vorwerk Influence of irradiated lung volumes on perioperative morbidity and mortality in patients after neoadjuvant radiochemotherapy for esophageal cancer Int J Radiat Oncol Biol Phys 77 2009 44 52
29. F. Fiorica, D. Di Bona, and F. Schepis Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis Gut 53 2004 925 930
30. J.D. Urschel, and H. Vasan A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer Am J Surg 185 2003 538 543
31. F.M. Hsu, Y.C. Lee, and J.M. Lee Association of clinical and dosimetric factors with postoperative pulmonary complications in esophageal cancer patients receiving intensity-modulated radiation therapy and concurrent chemotherapy followed by thoracic esophagectomy Ann Surg Oncol 16 2009 1669 1677